Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Martiat

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Leukemia|July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)A Delannoy, P Martiat, J L Gala, et al.
Annals of Hematology|March 5, 1998
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemiaE Van Den Neste, P Martiat, P Mineur, et al.
European Journal of Haematology|September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized studyP Martiat, J M Ghilain, A Ferrant, et al.
British Journal of Haematology|July 1, 1997
A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapseC Jacquy, B Delepaut, S Van Daele, et al.
British Journal of Haematology|July 1, 1990
Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primersP Martiat, D Maisin, M Philippe, et al.
Bone Marrow Transplantation|April 28, 1999
Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?C Jacquy, F Lambert, A Soree, et al.
Leukemia|August 1, 1991
Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosomeE Vandenberghe, P Martiat, M Baens, et al.
Bone Marrow Transplantation|May 1, 1995
Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remissionA Ferrant, C Doyen, A Delannoy, et al.
Leukemia|February 1, 1994
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patientF Guidez, W Huang, J H Tong, et al.
Blood|January 15, 1993
Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell linesP Martiat, P Lewalle, A S Taj, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Leukemia|July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)A Delannoy, P Martiat, J L Gala, et al.
Annals of Hematology|March 5, 1998
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemiaE Van Den Neste, P Martiat, P Mineur, et al.
European Journal of Haematology|September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized studyP Martiat, J M Ghilain, A Ferrant, et al.
British Journal of Haematology|July 1, 1997
A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapseC Jacquy, B Delepaut, S Van Daele, et al.
British Journal of Haematology|July 1, 1990
Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primersP Martiat, D Maisin, M Philippe, et al.
Bone Marrow Transplantation|April 28, 1999
Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?C Jacquy, F Lambert, A Soree, et al.
Leukemia|August 1, 1991
Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosomeE Vandenberghe, P Martiat, M Baens, et al.
Bone Marrow Transplantation|May 1, 1995
Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remissionA Ferrant, C Doyen, A Delannoy, et al.
Leukemia|February 1, 1994
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patientF Guidez, W Huang, J H Tong, et al.
Blood|January 15, 1993
Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell linesP Martiat, P Lewalle, A S Taj, et al.
Pageof 8